Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma

Withdrawn before enrolling · Phase 2

Conditions studied: Retinoblastoma, Eye Cancer

In brief

Phase II study of selective intra-arterial infusion of chemotherapy for intraocular retinoblastoma

Key facts

Study ID

NCT01151748

Run by

Stanford University

People needed

0

Starts

2010-09-01

Expected to finish

2012-03-01

Last updated by the study team

2012-05-14

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients diagnosed with advanced intraocular retinoblastoma (International Retinoblastoma Classification group D or E*).
• Patients with tumor recurrence or vitreous seeding following completion of systemic chemotherapy or previous radiation therapy.

You may not qualify if…

• Congenital brain anomaly identified on MRI.
• History of systemic coagulopathy.
• Evidence of extra ocular retinoblastoma on clinical examination or neuroimaging.

Where it is running

• Stanford University School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.